Crossmark

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review

Published Online: 2023-06-17

Published Print: 2023-10

Authors

Silberstein, Stephen

Spierings, Egilius L. H.

Kunkel, Todd
Funding

Funding for this research was provided by:

Collegium Pharmaceutical
License Information

Text and Data Mining valid from 2023-06-17

Version of Record valid from 2023-06-17
More Information

Article History

Received: 22 March 2023

Accepted: 17 May 2023

First Online: 17 June 2023

Document is current